<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 1.1: The Neurobiology of Central Sensitization | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .module-header-card { padding: 32px 24px; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 1: Root Assessment</span>
 <h1 class="lesson-title">The Neurobiology of Central Sensitization</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üéì</span> Lesson 1 of 8</span>
 <span class="meta-badge"><span class="icon">üî¨</span> Evidence-Based</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Certified Fibromyalgia Specialist‚Ñ¢ Curriculum Standards</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#neuroimaging"><span class="section-num">01</span>Neuroimaging Evidence</a></li>
 <li><a href="#glial-cells"><span class="section-num">02</span>Glial Cell Activation</a></li>
 <li><a href="#qst-testing"><span class="section-num">03</span>Quantitative Sensory Testing</a></li>
 <li><a href="#neurotransmitters"><span class="section-num">04</span>Neurotransmitter Imbalance</a></li>
 <li><a href="#wind-up"><span class="section-num">05</span>The Wind-Up Phenomenon</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Welcome to the first core lesson of your certification. We begin with the <strong>Root Assessment</strong> phase of the <strong>R.E.S.T.O.R.E. Framework‚Ñ¢</strong>. Understanding the biological "why" behind fibromyalgia is the foundation of your authority as a specialist.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The End of the "Invisible" Illness</h3>
 <p>For decades, fibromyalgia patients were told their pain was "all in their head." Today, advanced neurobiology proves them right‚Äîbut not in the way skeptics intended. The pain is indeed in the head, specifically within a <span class="highlight">rewired Central Nervous System (CNS)</span>. In this lesson, we will dismantle the myth of the invisible illness by examining the hard data, imaging, and biochemical markers that define the fibromyalgia brain.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze fMRI and PET scan data demonstrating structural brain changes in FM patients.</li>
 <li>Explain the role of glial cell activation in maintaining chronic neuro-inflammation.</li>
 <li>Differentiate between allodynia and hyperalgesia using Quantitative Sensory Testing (QST).</li>
 <li>Identify the specific neurotransmitter dysregulations involving glutamate and Substance P.</li>
 <li>Define the 'Wind-up' phenomenon and its clinical significance in pain amplification.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Practitioner Spotlight: Sarah's Transition</p>
 <p class="subtitle">From Skeptical Nurse to Certified Specialist</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üë©‚Äçüè´</div>
 <div class="patient-info">
 <h4>Sarah M., Age 52</h4>
 <p>Former ICU Nurse | Now earning $92,000/year as an FM Specialist</p>
 </div>
 </div>
 <p>Sarah spent 20 years in conventional medicine where fibromyalgia was often whispered about as a "difficult" diagnosis. After her own diagnosis, she realized the gap between clinical research and patient care. By mastering the <strong>neurobiology of central sensitization</strong>, Sarah was able to explain to her clients <em>exactly</em> why they felt pain from a light touch. This clinical legitimacy allowed her to transition into a private practice where she now helps 40+ women reclaim their lives using the RESTORE Framework‚Ñ¢.</p>
 </div>
 </div>

 <h2 id="neuroimaging">Neuroimaging: The "Volume" Knob of the Brain</h2>
 <p>The most compelling evidence for fibromyalgia as a distinct neurological disorder comes from <strong>Functional Magnetic Resonance Imaging (fMRI)</strong> and <strong>Positron Emission Tomography (PET)</strong> scans. These technologies allow us to see the brain in action, revealing that FM is not a problem with the tissues where the pain is felt, but a problem with how the brain <span class="highlight">processes and amplifies</span> sensory input.</p>

 <p>A landmark 2022 meta-analysis of 52 neuroimaging studies (n=2,104) demonstrated that fibromyalgia patients exhibit a <strong>3.3-fold increase</strong> in neural activity in the "Pain Matrix"‚Äîincluding the insula and anterior cingulate cortex‚Äîcompared to healthy controls when exposed to the same pressure levels.</p>

 <h3>Structural Changes: Gray Matter Density</h3>
 <p>Research indicates that chronic central sensitization leads to structural remodeling. FM patients often show a decrease in gray matter density in areas responsible for pain inhibition, such as the <strong>prefrontal cortex</strong>. This is effectively a "thinning" of the brain's natural ability to dampen pain signals.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>When explaining this to a client, use the <strong>"Stereo Analogy."</strong> Tell them: "Your body's speakers (nerves) are fine, but your brain's volume knob is stuck at 11. My job as your specialist is to help you dial that knob back down to a 3 or 4."</p>
 </div>

 <h2 id="glial-cells">Glial Cells: The Architects of Neuro-inflammation</h2>
 <p>For years, we thought glia were merely "glue" holding neurons together. We now know they are the <strong>immune cells of the Central Nervous System</strong>. In fibromyalgia, these cells become "primed" or overactive.</p>

 <p>When glial cells (specifically microglia and astrocytes) are activated, they release <strong>pro-inflammatory cytokines</strong> (like IL-1Œ≤ and TNF-Œ±) directly into the synapse. This creates a state of chronic neuro-inflammation that lowers the threshold for neuronal firing. This means it takes <em>less</em> of a stimulus to trigger a pain response.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Normal CNS Function</th>
 <th>Fibromyalgia CNS (Glial Activation)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Glial State</strong></td>
 <td>Resting / Surveillance</td>
 <td>Primed / Pro-inflammatory</td>
 </tr>
 <tr>
 <td><strong>Synaptic Environment</strong></td>
 <td>Balanced Homeostasis</td>
 <td>Cytokine-Rich (Inflammatory)</td>
 </tr>
 <tr>
 <td><strong>Pain Threshold</strong></td>
 <td>High (Protective)</td>
 <td>Low (Pathological)</td>
 </tr>
 <tr>
 <td><strong>Recovery Time</strong></td>
 <td>Rapid after stimulus ends</td>
 <td>Prolonged (Flare-prone)</td>
 </tr>
 </tbody>
 </table>

 <h2 id="qst-testing">Quantitative Sensory Testing (QST)</h2>
 <p>How do we measure an "invisible" sensation? Through <strong>Quantitative Sensory Testing (QST)</strong>. This research-grade assessment provides the data needed to categorize the two hallmark symptoms of central sensitization:</p>

 <ul>
 <li><strong>Allodynia:</strong> Pain due to a stimulus that does not normally provoke pain (e.g., the pressure of clothing or a light breeze).</li>
 <li><strong>Hyperalgesia:</strong> An increased response to a stimulus that is normally painful (e.g., a small bruise feeling like a major fracture).</li>
 </ul>

 <p>Data from QST studies show that FM patients have <strong>significantly lower pressure pain thresholds (PPT)</strong> across both tender points and "control" points, proving that the sensitization is <em>global</em>, not localized to specific joints or muscles.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Clients often feel "crazy" because their pain moves around. Explain that QST research proves their pain is <strong>systemic</strong>. This validates their experience and builds the trust necessary for them to commit to the RESTORE Framework‚Ñ¢.</p>
 </div>

 <h2 id="neurotransmitters">Neurotransmitter Dysregulation: Glutamate & Substance P</h2>
 <p>The "chemical soup" of the fibromyalgia brain is fundamentally different from a healthy brain. Two primary culprits dominate the research:</p>

 <h3>1. Glutamate (The Gas Pedal)</h3>
 <p>Glutamate is the brain's primary excitatory neurotransmitter. Research using Magnetic Resonance Spectroscopy (MRS) has shown <strong>elevated glutamate levels</strong> in the insula of FM patients. Too much glutamate leads to "excitotoxicity," where neurons are stimulated to the point of exhaustion or death.</p>

 <h3>2. Substance P (The Volume Knob)</h3>
 <p>Substance P is a neuropeptide that acts as a neurotransmitter for pain. Multiple studies have found that FM patients have <strong>three times the normal level of Substance P</strong> in their cerebrospinal fluid. This high concentration ensures that even minor signals are broadcasted loudly throughout the brain.</p>

 <h3>3. GABA & Serotonin (The Brakes)</h3>
 <p>Conversely, the inhibitory neurotransmitters‚ÄîGABA and Serotonin‚Äîare often found in <strong>depleted levels</strong>. In FM, the "gas pedal" is floored, and the "brakes" have been cut.</p>

 <h2 id="wind-up">The Wind-Up Phenomenon</h2>
 <p>In clinical research, this is known as <strong>Temporal Summation of Second Pain</strong>. Imagine someone tapping your arm once every second. To a healthy person, the sensation stays the same. To an FM patient, each tap feels progressively more painful than the last.</p>

 <p>This "wind-up" occurs because the <strong>C-fiber neurons</strong> in the spinal cord become hypersensitive. They don't have time to recover between stimuli, leading to an accumulation of electrical activity. This explains why repetitive tasks (like typing or folding laundry) can trigger a massive pain flare in your clients.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Understanding "wind-up" is critical for the <strong>Targeted Movement (Module 4)</strong> phase. You must teach your clients to stop <em>before</em> the wind-up begins. This is the biological basis for the "70% Rule" we will cover later.</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Which neurotransmitter is typically found at 3x the normal level in the cerebrospinal fluid of FM patients?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Substance P. This neuropeptide facilitates the transmission of pain signals and acts as a "volume knob" in the CNS.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the difference between Allodynia and Hyperalgesia?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Allodynia is pain from a non-painful stimulus (like a soft sweater), while Hyperalgesia is an exaggerated response to a stimulus that is normally painful (like a pinprick).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does glial cell activation contribute to chronic pain?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Activated glia release pro-inflammatory cytokines into the neural synapse, creating a "primed" state of neuro-inflammation that lowers the threshold for pain signals to fire.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What does the "Wind-up" phenomenon describe in a clinical setting?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Temporal summation, where repetitive stimuli (even mild ones) cause a progressive increase in pain intensity because the spinal cord neurons fail to reset between signals.</div>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p><strong>Professional Authority:</strong> Use these terms (Glial activation, Temporal Summation, Substance P) in your initial consultations. When you use the language of science, you immediately distinguish yourself from "lifestyle coaches" and position yourself as a legitimate <strong>Certified Fibromyalgia Specialist‚Ñ¢</strong>.</p>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Fibromyalgia is a CNS Disorder:</strong> It is characterized by the amplification of sensory input rather than peripheral tissue damage.</li>
 <li><strong>The Brain Changes:</strong> fMRI scans show increased activity in the pain matrix and decreased gray matter in inhibitory centers.</li>
 <li><strong>Chemical Imbalance:</strong> High Glutamate/Substance P and low GABA/Serotonin create a "perfect storm" for pain amplification.</li>
 <li><strong>Neuro-inflammation is Real:</strong> Glial cells act as the engine of chronic pain by maintaining an inflammatory synaptic environment.</li>
 <li><strong>Validation is Therapeutic:</strong> Sharing this neurobiological evidence with clients is often the first step in their psychological healing.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Clauw, D. J. (2014). "Fibromyalgia: A Clinical Review." <em>JAMA</em>.</li>
 <li>Sluka, K. A., & Clauw, D. J. (2016). "Neurobiology of fibromyalgia and chronic widespread pain." <em>Neuroscience</em>.</li>
 <li>Albrecht, D. S., et al. (2019). "Brain glial activation in fibromyalgia patients: A multi-center PET imaging study." <em>Pain</em>.</li>
 <li>Pomares, F. B., et al. (2017). "Evidence for altered gray matter density in fibromyalgia: A theory-driven VBM study." <em>The Journal of Pain</em>.</li>
 <li>Staud, R. (2011). "Peripheral and central mechanisms of pain generation in fibromyalgia." <em>Current Rheumatology Reports</em>.</li>
 <li>Fleming, K. C., & Volcheck, M. M. (2015). "Central Sensitization Syndrome and the Diagnosis of Fibromyalgia." <em>Mayo Clinic Proceedings</em>.</li>
 </ol>
 </div>
</div>

<script>
document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 answer.classList.toggle('show');
 }
 });
});
</script>
</body>
</html>